D
Anixa Biosciences, Inc. ANIX
$3.30 -$0.11-3.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Net Income 31.10% 11.12% 2.18% -7.17% -30.51%
Total Depreciation and Amortization 200.00% -25.00% -30.77% -25.00% -72.73%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -33.76% -6.64% -36.82% -18.63% 4.92%
Change in Net Operating Assets 86.49% -69.03% -72.26% 299.39% -385.60%
Cash from Operations 42.83% -3.23% -25.77% 52.92% -82.91%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -130.58% 321.22% 1,995.35% 246.21% 377.96%
Cash from Investing -130.58% 321.22% 1,995.35% 246.21% 377.96%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 612.50% -99.87% -- -- 9,500.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 11.51% 100.77% -100.77% -- --
Cash from Financing 1,194.63% -97.99% -100.75% -62.01% 4,866.67%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -280.43% 28,666.67% -362.65% 102.01% 109.50%